AWM
ITOS

Avior Wealth Management’s iTeos Therapeutics ITOS Stock Holding History

Avior Wealth Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$68 – 2992
2024
Q1 		$68 Buy
+5
New +$54 ﹤0.01% 3359

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avior Wealth Management's ITOS Position: Q2 2024 in Review

Avior Wealth Management sold out of iTeos Therapeutics (ITOS) in Q2 2024, closing a stake of 5 shares — an estimated $68 sold.

Avior Wealth Management first reported a position in ITOS in Q1 2024 and held it in 1 quarter. The position peaked at $68 in Q1 2024. 137 funds tracked by Wall St. Rank hold ITOS as of Q2 2024.

  • Avior Wealth Management reported no remaining iTeos Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 5 iTeos Therapeutics shares in Q2 2024, an estimated $68.
  • Avior Wealth Management first reported a position in iTeos Therapeutics in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's iTeos Therapeutics position peaked at $68 in Q1 2024.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.